Phase II study of weekly paclitaxel and carboplatin followed by oral navelbine in patients with triple negative metastatic/recurrent breast cancer previously treated with adjuvant anthracycline and taxotere.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e12557-e12557 ◽  
Author(s):  
Inas Ibraheim Abdel Halim ◽  
Wael El-Sadda ◽  
Mostafa El-Ebrashy ◽  
Mohamed El Ashry
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Triple Negative ◽  
Phase Ii Study ◽  
Recurrent Breast Cancer ◽  
Weekly Paclitaxel ◽  
Previously Treated ◽  
Recurrent Breast

A multicenter phase II study of S-1 combined with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e11528-e11528
Author(s):  
U. Toh ◽  
N. Iwakuma ◽  
H. Otsuka ◽  
M. Takenaka ◽  
E. Ogo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Recurrent Breast Cancer ◽  
Multicenter Phase ◽  
Recurrent Breast

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer

The Breast ◽  
2013 ◽  
Vol 22 (5) ◽  
pp. 650-656 ◽  
Author(s):  
Giuseppe Curigliano ◽  
Xavier Pivot ◽  
Javer Cortés ◽  
Anthony Elias ◽  
Rossano Cesari ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Phase Ii Study ◽  
Standard Of Care ◽  
Randomized Phase Ii ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document